Skip to content

Clinical trials

Phase 1/2 Brain Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Phase: Phase 1/2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20111
20122
20151
20172
20181
20192
20201
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting2
Terminated2
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AC Immune SA2
Herantis Pharma Plc.2
AskBio France, SAS, a subsidiary of AskBio Inc.1
Assistance Publique - Hôpitaux de Paris1
BBB-Therapeutics B.V.1
Forge Biologics, Inc1
Jichi Medical University1
M.D. Anderson Cancer Center1
Massachusetts General Hospital1
ModernaTX, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases18
Central Nervous System Diseases13
Nervous System Diseases10
Movement Disorders5
Neurodegenerative Diseases5
Parkinson Disease5
Brain Neoplasms4
Alzheimer Disease3
Central Nervous System Neoplasms3
Dementia3

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.